{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:04:54Z","timestamp":1761563094422,"version":"3.40.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jceh.2025.102505","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:58:09Z","timestamp":1737593889000},"page":"102505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Managing Complex Hepatocellular Carcinoma Subtypes: Diffuse Infiltrative, Large Tumours, and Tumour Rupture\u2014The Challenges and Strategies"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-2623","authenticated-orcid":false,"given":"Ashok","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Mukund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-3384","authenticated-orcid":false,"given":"Deepti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-1014","authenticated-orcid":false,"given":"Subin","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-1765","authenticated-orcid":false,"given":"Won-Mook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.102505_bib1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jceh.2025.102505_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101391","article-title":"Changing etiological spectrum of hepatocellular carcinoma in India-A systematic review and meta-analysis","volume":"14","author":"Giri","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101447","article-title":"Epidemiology of hepatocellular carcinoma in India - an updated review for 2024","volume":"14","author":"Giri","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib5","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1245\/s10434-012-2336-0","article-title":"Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes","volume":"19","author":"Kneuertz","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib6","article-title":"How should we assign large infiltrative hepatocellular carcinomas for staging?","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jceh.2025.102505_bib7","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(19841115)54:10<2165::AID-CNCR2820541017>3.0.CO;2-7","article-title":"Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification","volume":"54","author":"Okuda","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2025.102505_bib8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s11605-011-1614-7","article-title":"Infiltrating hepatocellular carcinoma: seeing the tree through the forest","volume":"15","author":"Demirjian","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2025.102505_bib9","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1245\/s10434-015-4786-7","article-title":"Infiltrative hepatocellular carcinoma: natural history and comparison with multifocal, nodular hepatocellular carcinoma","volume":"22","author":"Yopp","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/gut.48.1.110","article-title":"Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development","volume":"48","author":"Benvegn\u00f9","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2025.102505_bib11","first-page":"266","article-title":"Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments","volume":"53","author":"Myung","year":"2006","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.jceh.2025.102505_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.102505_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cgh.2012.12.030","article-title":"Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma","volume":"11","author":"Mehta","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jmri.27553","article-title":"Hepatocellular carcinoma with atypical imaging features: review of the morphologic hepatocellular carcinoma subtypes with radiology-pathology correlation","volume":"55","author":"Bello","year":"2022","journal-title":"J\u00a0Magn Reson Imag"},{"key":"10.1016\/j.jceh.2025.102505_bib15","article-title":"Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature","volume":"8","author":"Xiong","year":"2020","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jmri.10336","article-title":"Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations","volume":"18","author":"Kanematsu","year":"2003","journal-title":"J\u00a0Magn Reson Imag"},{"key":"10.1016\/j.jceh.2025.102505_bib17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1572-0241.2006.00443.x","article-title":"Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?","volume":"101","author":"Farinati","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.102505_bib18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1478-3231.2005.01111.x","article-title":"Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma","volume":"25","author":"Tada","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.102505_bib19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1440-1746.2002.02806.x","article-title":"Clinicopathologic features\u00a0of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone","volume":"17","author":"Okuda","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib20","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jfma.2022.01.005","article-title":"Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma","volume":"121","author":"Wang","year":"2022","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jceh.2025.102505_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib22","article-title":"2023 update of Indian national association for study of the liver consensus on management of intermediate and advanced hepatocellular carcinoma: the Puri III recommendations","volume":"14","author":"Kumar","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2023.10.003","article-title":"INASL consensus on management of HCC: navigating an evolving field","volume":"14","author":"Singal","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jceh.2019.09.007","article-title":"2019 update of Indian national association for study of the liver consensus on prevention, diagnosis, and management of hepatocellular carcinoma in India: the Puri II recommendations","volume":"10","author":"Kumar","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2025.102505_bib25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jceh.2014.04.003","article-title":"The Indian national association for study of the liver (INASL) consensus on prevention, diagnosis and management of hepatocellular carcinoma in India: the puri recommendations","volume":"4","author":"Kumar","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib26","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/jgh.14705","article-title":"NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging","volume":"34","author":"Su","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clinimag.2020.10.011","article-title":"Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI","volume":"70","author":"Vernuccio","year":"2021","journal-title":"Clin Imag"},{"key":"10.1016\/j.jceh.2025.102505_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2023.101307","article-title":"Definitive role of contrast-enhanced endoscopic ultrasound (EUS) in the diagnosis of hepatocellular carcinoma with non-diagnostic cross-sectional imaging: a case report","volume":"14","author":"Sonthalia","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000505191","article-title":"How to best detect portal vein tumor thrombosis in patients with hepatocellular carcinoma meeting the milan criteria: gadoxetic acid-enhanced MRI versus contrast-enhanced CT","volume":"9","author":"Bae","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jceh.2025.102505_bib30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jceh.2023.03.006","article-title":"Hepatocellular carcinoma with hepatic vein and\u00a0inferior vena cava invasion","volume":"13","author":"Shukla","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib31","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00261-020-02870-3","article-title":"Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma","volume":"46","author":"Nisiewicz","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jceh.2025.102505_bib32","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jvir.2017.05.017","article-title":"Single-Center comparison of overall survival and toxicities in patients with infiltrative hepatocellular carcinoma treated with yttrium-90 radioembolization or drug-eluting embolic transarterial chemoembolization","volume":"28","author":"McDevitt","year":"2017","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2025.102505_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1159\/000452208","article-title":"Diffuse infiltrative hepatocellular carcinoma with portal vein tumor thrombosis completely cured by transcatheter arterial chemoembolization: case report with 8-year follow-up","volume":"10","author":"Kim","year":"2016","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.jceh.2025.102505_bib34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3892\/mco.2014.391","article-title":"Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: a retrospective comparative study","volume":"2","author":"Dai","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2015.02.010","article-title":"Transarterial chemoembolization: modalities, indication, and patient selection","volume":"62","author":"Sieghart","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0042-1754361","article-title":"Indian College of radiology and imaging guidelines on interventions in hepatocellular carcinoma","volume":"32","author":"Gupta","year":"2022","journal-title":"Indian J Radiol Imag"},{"key":"10.1016\/j.jceh.2025.102505_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.747496","article-title":"Infiltrative hepatocellular carcinoma: transcatheter arterial chemoembolization versus hepatic arterial infusion chemotherapy","volume":"11","author":"An","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1010824","article-title":"Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: a systematic review with meta-analysis","volume":"10","author":"Si","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jceh.2025.102505_bib39","first-page":"39","article-title":"Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"4","author":"Holliday","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3348\/kjr.2014.15.4.464","article-title":"Transcatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survival","volume":"15","author":"Han","year":"2014","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jceh.2025.102505_bib41","article-title":"Extremes of liver transplantation for hepatocellular carcinoma","volume":"8","author":"Gr\u0105t","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jceh.2025.102505_bib42","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1097\/TXD.0000000000000707","article-title":"Infiltrative hepatocellular carcinoma with portal vein tumor thrombosis treated with a single high-dose Y90 radioembolization and subsequent liver transplantation without a recurrence","volume":"3","author":"Dendy","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jceh.2025.102505_bib43","article-title":"Solitary large hepatocellular carcinoma: staging and treatment strategy","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.102505_bib44","doi-asserted-by":"crossref","DOI":"10.1590\/0102-672020190001e1505","article-title":"Surgical management of large hepatocellular carcinoma: the first single-center study from western India","volume":"33","author":"Wagle","year":"2020","journal-title":"Arq Bras Cir Dig"},{"key":"10.1016\/j.jceh.2025.102505_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.674603","article-title":"Efficacy of liver resection for single large hepatocellular carcinoma in child-pugh A cirrhosis: analysis of a nationwide cancer registry database","volume":"11","author":"Hong","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib46","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.102505_bib47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/17474124.2022.2091545","article-title":"Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study","volume":"16","author":"Zhao","year":"2022","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib48","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jceh.2021.02.003","article-title":"Survival and outcome in patients receiving drug-eluting beads transarterial chemoembolization for large hepatocellular carcinoma (>5 cm)","volume":"11","author":"Mukund","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib49","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1748-717X-9-120","article-title":"The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities","volume":"9","author":"Que","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009249","article-title":"Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma","volume":"96","author":"Kuo","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2025.102505_bib52","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20181053","article-title":"Stereotactic body radio therapy for inoperable large hepatocellular cancers: results from a clinical audit","volume":"92","author":"Chopra","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jceh.2025.102505_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijrobp.2022.05.021","article-title":"Combination transarterial chemoembolization and stereotactic body radiation therapy for unresectable single large hepatocellular carcinoma: results from a prospective phase 2 trial","volume":"114","author":"Buckstein","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jceh.2025.102505_bib54","article-title":"Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: a meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.102505_bib55","doi-asserted-by":"crossref","first-page":"24537","DOI":"10.18632\/oncotarget.25224","article-title":"Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jceh.2025.102505_bib56","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s12072-022-10423-7","article-title":"Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial","volume":"16","author":"Guo","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.102505_bib57","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.102505_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.839605","article-title":"Effects of stereotactic body radiation therapy plus PD-1 inhibitors for patients with transarterial chemoembolization refractory","volume":"12","author":"Xiang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061798","article-title":"Treatment strategy for intermediate-stage hepatocellular carcinoma: transarterial chemoembolization, systemic therapy, and conversion therapy","volume":"15","author":"Hatanaka","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jceh.2025.102505_bib60","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/2326-6066.CIR-14-0069","article-title":"Combining radiation and immunotherapy: a new systemic therapy for solid tumors?","volume":"2","author":"Tang","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jceh.2025.102505_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000533425","article-title":"Survival outcome analysis of stereotactic body radiotherapy and immunotherapy (SBRT-IO) versus SBRT-alone in unresectable hepatocellular carcinoma","volume":"13","author":"Chiang","year":"2024","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jceh.2025.102505_bib62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/hpb.12416","article-title":"Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery","volume":"17","author":"Lim","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jceh.2025.102505_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244939","article-title":"Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: when East meets West","volume":"16","author":"Yen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.102505_bib64","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1038\/s41598-021-83868-9","article-title":"Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis","volume":"11","author":"Bogdanovic","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2025.102505_bib65","article-title":"Chemoembolization for single large hepatocellular carcinoma with preserved liver function: analysis of factors predicting clinical outcomes in a 302 patient cohort","volume":"11","author":"Kim","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jceh.2025.102505_bib66","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/liv.12436","article-title":"Therapeutic benefit of radiotherapy in huge (\u226510 cm) unresectable hepatocellular carcinoma","volume":"34","author":"Kim","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.102505_bib67","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.suronc.2019.01.006","article-title":"Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: a propensity score matched analysis","volume":"28","author":"Wong","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib68","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3892\/mco.2014.304","article-title":"Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (\u226510 cm) hepatocellular carcinomas: a clinical study","volume":"2","author":"Zhong","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jceh.2018.04.002","article-title":"Rupture of hepatocellular carcinoma: a review of literature","volume":"9","author":"Sahu","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib70","article-title":"Ruptured hepatocellular carcinoma: current status of research","volume":"12","author":"Xia","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jceh.2021.05.010","article-title":"Spontaneous rupture of hepatocellular carcinoma: new insights","volume":"12","author":"Obeidat","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib72","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/MEG.0000000000001115","article-title":"Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas","volume":"30","author":"Joliat","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.102505_bib73","article-title":"Predictors of spontaneous rupture of hepatocellular carcinoma and clinical outcomes following hepatectomy","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13061021","article-title":"Spontaneously ruptured hepatocellular carcinoma: computed tomography-based assessment","volume":"13","author":"Sandomenico","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jceh.2025.102505_bib75","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s12072-022-10403-x","article-title":"Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma","volume":"16","author":"Wang","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.102505_bib76","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.3748\/wjg.v21.i24.7488","article-title":"Prognostic factors of spontaneously ruptured hepatocellular carcinoma","volume":"21","author":"Han","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.102505_bib77","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1007\/s00432-023-04774-3","article-title":"Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study","volume":"149","author":"Zhang","year":"2023","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib78","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archsurg.134.10.1103","article-title":"Spontaneous rupture of hepatocellular carcinoma: conservative management and selective intervention","volume":"134","author":"Leung","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.jceh.2025.102505_bib79","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00270-020-02514-5","article-title":"A\u00a0meta-analysis of TAE\/TACE versus emergency surgery in the treatment of ruptured HCC","volume":"43","author":"Xu","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2025.102505_bib80","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1007\/s11605-018-3930-7","article-title":"Outcomes and prognostic factors of spontaneously ruptured hepatocellular carcinoma","volume":"23","author":"Zhang","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jceh.2025.102505_bib81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/ijri.IJRI_252_18","article-title":"Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma","volume":"29","author":"Patidar","year":"2019","journal-title":"Indian J Radiol Imag"},{"key":"10.1016\/j.jceh.2025.102505_bib82","article-title":"Research progress of spontaneous ruptured hepatocellular carcinoma: systematic review and meta-analysis","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2025.102505_bib83","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1038\/s41598-022-12350-x","article-title":"Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor rupture","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2025.102505_bib84","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s11605-023-05860-0","article-title":"Meta-analysis of prognostic factors for overall survival among resected patients with spontaneous ruptured hepatocellular carcinoma","volume":"27","author":"Lv","year":"2023","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jceh.2025.102505_bib85","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.hpb.2020.08.001","article-title":"Treatment of spontaneously ruptured hepatocellular carcinoma: use of laparoscopic microwave ablation and washout","volume":"23","author":"Baimas-George","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jceh.2025.102505_bib86","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/lap.2016.0118","article-title":"Early laparoscopic radiofrequency ablation for spontaneous rupture of hepatocellular carcinoma","volume":"26","author":"Gao","year":"2016","journal-title":"J\u00a0Laparoendosc Adv Surg Tech"},{"key":"10.1016\/j.jceh.2025.102505_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jceh.2025.102505_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.769233","article-title":"Prognostic influence of spontaneous tumor rupture in patients with hepatocellular carcinoma after hepatectomy: a meta-analysis of observational studies","volume":"8","author":"Xu","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.jceh.2025.102505_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.722098","article-title":"Outcomes of living donor liver transplantation in patients with a history of ruptured hepatocellular carcinoma","volume":"8","author":"Lee","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.jceh.2025.102505_bib90","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.ejso.2019.03.044","article-title":"Impact of spontaneous rupture on the survival outcomes after liver resection for hepatocellular carcinoma: a propensity matched analysis comparing ruptured versus non-ruptured tumors","volume":"45","author":"Chua","year":"2019","journal-title":"Eur J Surg Oncol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T22:52:08Z","timestamp":1746226328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0973688325000052"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.102505","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing Complex Hepatocellular Carcinoma Subtypes: Diffuse Infiltrative, Large Tumours, and Tumour Rupture\u2014The Challenges and Strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.102505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102505"}}